Platelet aggregation inhibitors is an academic concept and research field focused on the study and development of pharmacological agents that prevent or reduce the aggregation of blood platelets. This area investigates the biochemical pathways and cellular mechanisms governing platelet activation and aggregation, significant for developing therapeutic strategies to prevent or treat thrombotic disorders.